News

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 ...
A gene therapy trial in California at the end of the year has the potential to greatly impact Charli's quality of life.
Taking center stage at the American Society of Gene and Cell Therapy meeting was the first-ever reported case of a ...
When CRISPR was first introduced as a gene-editing tool in 2012, the world was in awe of all the possibilities it held - ...
The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...
Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...
Infant With Rare, Incurable Disease Is First to Successfully Receive Personalized Gene Therapy Treatment May 15, 2025 — A research team has developed and safely delivered a personalized gene ...
SAN ANTONIO — Charli is fighting an extremely rare and terminal condition often referred to as childhood dementia at just ...